C. Van de Wiele

发表

A review of small animal imaging planar and pinhole spect Gamma camera imaging.

B. Cornelissen, K. Audenaert, K. Peremans, 2005, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.

Toward clinical application of neuropsychological activation probes with SPECT: a spatial working memory task.

André Vandierendonck, Ingeborg Goethals, Kurt Audenaert, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

FDG-PET imaging in HIV infection and tuberculosis.

Alex Maes, Mike Sathekge, Christophe Van de Wiele, 2013, Seminars in nuclear medicine.

Validation of gated blood-pool SPECT cardiac measurements tested using a biventricular dynamic physical phantom.

J. De Sutter, P. Verdonck, P. Segers, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Peptide radiopharmaceuticals for diagnosis and therapy

C. Van de Wiele, F. Corsetti, M. Chianelli, 2001, European Journal of Nuclear Medicine.

Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study

G. Slegers, C. Van de Wiele, R. Dierckx, 2000, European Journal of Nuclear Medicine.

Radiolabeled immunotherapy in non-Hodgkin's lymphoma treatment: the next step

C. Van de Wiele, R. Dierckx, A. Otte, 2009, Nuclear medicine communications.

Review of clinically accessible methods to determine lean body mass for normalization of standardized uptake values.

A. Maes, C. Van de Wiele, H. Pottel, 2016, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Single-Photon Emission Computed Tomographic Imaging of the Early Time Course of Therapy-Induced Cell Death Using Technetium 99m Tricarbonyl His-Annexin A5 in a Colorectal Cancer Xenograft Model

C. Reutelingsperger, P. Pauwels, C. Van de Wiele, 2012, Molecular imaging.

Absolute 24 h quantification of 99Tcm-DMSA uptake in patients with severely reduced kidney function: a comparison with 51Cr-EDTA clearance.

C. Van de Wiele, R. Dierckx, J. Versijpt, 1999, Nuclear medicine communications.

Biodistribution and dosimetry of (iodine-123)-iodomethyl-N,N-diethyltamoxifen, an (anti)oestrogen receptor radioligand

J. De Sutter, H. Thierens, G. Slegers, 1999, European Journal of Nuclear Medicine.

57Co-EDTA renal imaging in rats

H. Thierens, C. Van de Wiele, R. Dierckx, 2000, Nuclear medicine communications.

Renal Toxicity after Radionuclide Therapy

C. Van de Wiele, R. Dierckx, S. Weiner, 2004, Radiation research.

Quorum Sensing Peptides Selectively Penetrate the Blood-Brain Barrier

K. Peremans, C. Van de Wiele, Yorick Janssens, 2015, PloS one.

Technetium-99m sestamibi imaging in paediatric neuroblastoma and ganglioneuroma and its relation to P-glycoprotein

F. Speleman, J. Philippé, C. Van de Wiele, 1999, European Journal of Nuclear Medicine.

Biodistribution and dosimetry of (99m)Tc-depreotide (P829) in patients suffering from breast carcinoma.

H. Thierens, B. Van Den Bossche, C. Van de Wiele, 2004, Cancer biotherapy & radiopharmaceuticals.

Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals

A. Maes, Y. D'Asseler, C. Van de Wiele, 2012, Nuclear medicine communications.

Impact of FDG PET on the management of TBC treatment. A pilot study.

A. Maes, C. Van de Wiele, H. Pottel, 2010, Nuklearmedizin. Nuclear medicine.

Sequential 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy.

G. Slegers, I. Goethals, C. Van de Wiele, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The immune system and cancer.

C. Van de Wiele, D. Loose, 2009, Cancer biotherapy & radiopharmaceuticals.

High performance liquid chromatographic determination of 123-I labeled tamoxifen metabolites in human plasma.

G. Slegers, C. Van de Wiele, R. Dierckx, 2001, Nuclear medicine and biology.

A Prospective Investigation of Tumor Hypoxia Imaging with 68Ga-Nitroimidazole PET/CT in Patients with Carcinoma of the Cervix Uteri and Comparison with 18F-FDG PET/CT: Correlation with Immunohistochemistry

A. Maes, C. Van de Wiele, J. Jeong, 2022, Journal of clinical medicine.

The Utility of Metabolic Parameters on Baseline F-18 FDG PET/CT in Predicting Treatment Response and Survival in Paediatric and Adolescent Hodgkin Lymphoma

C. Van de Wiele, M. Sathekge, M. Vorster, 2021, Journal of clinical medicine.

Impact of PET reconstruction protocols on quantification of lesions that fulfil the PERCIST lesion inclusion criteria

A. Maes, C. Van de Wiele, H. Pottel, 2018, EJNMMI Physics.

Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serum.

J. V. van Meerbeeck, R. Vanholder, C. Van de Wiele, 2009, Clinical chemistry.

Metabolic correlates of tumour hypoxia in malignant canine mammary carcinoma.

P. Pauwels, K. Peremans, C. Van de Wiele, 2011, Research in veterinary science.

68Ga-PSMA-11 PET/CT Initial Staging in Black and White South African Males with ISUP Grade Group 1 and 2 Prostate Adenocarcinoma

A. Maes, C. Van de Wiele, M. Sathekge, 2022, Biomedicines.

Practical Considerations When Interpreting FDG PET/CT Imaging for Staging and Treatment Response Assessment in Melanoma Patients.

C. Van de Wiele, B. De Spiegeleer, Gebreurs Juanito, 2021, Seminars in nuclear medicine.

Prognostic value of CD25 expression on lymphocytes and tumor cells in squamous-cell carcinoma of the head and neck.

C. Van de Wiele, R. Dierckx, A. Signore, 2008, Cancer biotherapy & radiopharmaceuticals.

Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.

H. Thierens, G. Slegers, C. Van de Wiele, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

In vivo apoptosis detection with radioiodinated Annexin V in LoVo tumour-bearing mice following Tipifarnib (Zarnestra, R115777) farnesyltransferase inhibitor therapy.

B. Cornelissen, G. Slegers, C. Van de Wiele, 2005, Nuclear medicine and biology.

Radiolabelled thymidines and deoxyuridines for measuring cellular proliferation in tumours--an update

C. Van de Wiele, R. Dierckx, M. Peeters, 2002, Nuclear medicine communications.

67Gallium citrate scintigraphy to assess metastatic spread in a dog with an oral melanoma.

K. Peremans, C. Van de Wiele, G. Grinwis, 2009, The Journal of small animal practice.

In vitro 2-deoxy-2-[18F]fluoro-D-glucose uptake: practical considerations.

I. Goethals, C. Van de Wiele, B. Lambert, 2012, Cancer biotherapy & radiopharmaceuticals.

Fluorine-18 Fluorodeoxyglucose-Positron Emission Tomography: A Highly Accurate Imaging Modality for the Diagnosis of Chronic Musculoskeletal Infections

C. Van de Wiele, R. Dierckx, K. D. De Smet, 2001 .

Nuclear Medicine Imaging For Prediction or Early Assessment of Response to Chemotherapy in Patients Suffering From Breast Carcinoma

C. Van de Wiele, R. Dierckx, A. Signore, 2002, Breast Cancer Research and Treatment.

Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumour imaging?

G. Slegers, C. Van de Wiele, R. Dierckx, 2001, Nuclear medicine communications.

FDG uptake in primary squamous cell carcinoma of the head and neck

I. Goethals, C. Van de Wiele, M. Peeters, 2010, Nuklearmedizin.

Negative 18F-FDG PET and positive CT and MRI findings in multifocal splenic hamartoma.

A. Maes, C. Van de Wiele, K. Verstraete, 2017, Hellenic journal of nuclear medicine.

Automatic quantification of defect size using normal templates: a comparative clinical study of three commercially available algorithms

Yves D'Asseler, J. De Sutter, G. De Backer, 2000, European Journal of Nuclear Medicine.

Fibrinogen and C-reactive protein on admission as markers of final infarct size after primary angioplasty for acute myocardial infarction.

J. De Sutter, G. De Backer, M. D. De Buyzere, 2001, Atherosclerosis.

Use of 18F-FDG PET to Predict Response to First-Line Tuberculostatics in HIV-Associated Tuberculosis

Alex Maes, Mike Sathekge, Christophe Van de Wiele, 2011, The Journal of Nuclear Medicine.

Reply: 18F-FDG PET/CT as a Sensitive and Early Treatment Monitoring Tool: Will This Become the Major Thrust for Its Clinical Application in Infectious and Inflammatory Disorders?

A. Maes, C. Van de Wiele, M. Sathekge, 2012, The Journal of Nuclear Medicine.

Fluorodeoxyglucose uptake by lymph nodes of HIV patients is inversely related to CD4 cell count

A. Maes, C. Van de Wiele, M. Sathekge, 2010, Nuclear medicine communications.

Receptor imaging in oncology by means of nuclear medicine: current status.

B. Van Den Bossche, C. Van de Wiele, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

QT dispersion is not related to infarct size or inducibility in patients with coronary artery disease and life threatening ventricular arrhythmias

L. Jordaens, J. De Sutter, G. De Backer, 1999, Heart.

99mTc-HYNIC Annexin-V imaging of primary head and neck carcinoma

G. Slegers, C. Van de Wiele, R. Dierckx, 2004, Nuclear medicine communications.

Intraobserver, interobserver, and day-to-day reproducibility of quantitative 99mTc-HYNIC annexin-V imaging in head and neck carcinoma.

C. Van de Wiele, R. Dierckx, S. Rottey, 2004, Cancer biotherapy & radiopharmaceuticals.

Reverse redistribution on thallium-201 single-photon emission tomography after primary angioplasty: a one-year follow-up study

J. De Sutter, M. D. De Buyzere, C. Van de Wiele, 1999, European Journal of Nuclear Medicine.

Cardiac fluorine-18 fluorodeoxyglucose imaging using a dual-head gamma camera with coincidence detection: a clinical pilot study

J. De Sutter, Y. D'Asseler, C. Van de Wiele, 2000, European Journal of Nuclear Medicine.

Whole-body bone scan findings in X-linked hypophosphatemia.

C. Van de Wiele, R. Dierckx, M. Simons, 1996, Clinical nuclear medicine.

68Ga-DOTA-TATE PET/CT imaging for differentiating a sarcoid-like reaction from progression following immunotherapy in a triple-negative breast carcinoma patient

A. Maes, C. Van de Wiele, Anne-Leen Deleu, 2020, European Journal of Nuclear Medicine and Molecular Imaging.

Evaluation of glucose uptake by skeletal muscle tissue and subcutaneous fat in HIV-infected patients with and without lipodystrophy using FDG-PET

A. Maes, C. Van de Wiele, M. Sathekge, 2010, Nuclear medicine communications.

Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy

A. Maes, F. Giesel, C. Van de Wiele, 2020, The Journal of Nuclear Medicine.

PSMA-Targeting Positron Emission Agents for Imaging Solid Tumors Other Than Non-Prostate Carcinoma: A Systematic Review

A. Maes, C. Van de Wiele, B. De Spiegeleer, 2019, International journal of molecular sciences.

Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents.

J. Foidart, B. Cornelissen, G. Slegers, 2006, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Targeting monocytes and macrophages by means of SPECT and PET.

A. Maes, C. Van de Wiele, M. Sathekge, 2014, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

18FDG PET versus high-dose 67Ga scintigraphy for restaging and treatment follow-up of lymphoma patients

B. Van Den Bossche, C. Van de Wiele, R. Dierckx, 2002, Nuclear medicine communications.

Early prediction of endocrine therapy effect in advanced breast cancer patients using 99mTc-depreotide scintigraphy.

B. Van Den Bossche, C. Van de Wiele, A. Signore, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Apoptosis Imaging in Oncology by Means of Positron Emission Tomography: A Review

C. Van de Wiele, B. De Spiegeleer, M. Sathekge, 2021, International journal of molecular sciences.

In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells.

J. Philippé, Y. D'Asseler, C. Reutelingsperger, 2010, Nuclear medicine and biology.

FDG uptake, a surrogate of tumour hypoxia?

C. Van de Wiele, R. Dierckx, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

Principal component analysis of texture features derived from FDG PET images of melanoma lesions

C. Van de Wiele, Sathekge Mike, Maes Alex, 2022, EJNMMI Physics.

Quantitative p retreatment VOI analysis of liver metastases. (99m)Tc-MAA SPECT/CT and FDG PET/CT in relation with treatment response to SIRT.

A. Maes, Y. D'Asseler, C. Van de Wiele, 2013, Nuklearmedizin. Nuclear medicine.

Forcing cancer cells to commit suicide.

Marc Peeters, Christophe Van de Wiele, C. Van de Wiele, 2009, Cancer biotherapy & radiopharmaceuticals.

mCRPC Patients Receiving 225Ac-PSMA-617 Therapy in the Post–Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis

A. Maes, C. Van de Wiele, F. Bruchertseifer, 2022, The Journal of Nuclear Medicine.

The Quorum Sensing Peptide EntF* Promotes Colorectal Cancer Metastasis in Mice: A New Factor in the Microbiome-Host Interaction

D. Laukens, O. De Wever, C. Van de Wiele, 2020 .

In vivo evaluation of [(123)I]-3-(4-iodobenzyl)-1,2,3,4-tetrahydro-8-hydroxychromeno[3,4-c]pyridin-5-one: a presumed dopamine D4 receptor ligand for SPECT studies.

G. Slegers, C. Van de Wiele, V. Kersemans, 2005, Nuclear medicine and biology.

99Tcm labelled HL91 versus computed tomography and biopsy for the visualization of tumour recurrence of squamous head and neck carcinoma

Y. D'Asseler, C. Van de Wiele, R. Dierckx, 2001 .

Synthesis and in vitro evaluation of 123I-labelled human recombinant annexin V.

G. Slegers, J. Philippé, C. Van de Wiele, 2001, Biomolecular engineering.

99Tc(m) labelled HL91 versus computed tomography and biopsy for the visualization of tumour recurrence of squamous head and neck carcinoma.

Y. D'Asseler, C. Van de Wiele, R. Dierckx, 2001, Nuclear medicine communications.

18 F-Fluorodeoxyglucose triple-headed coincidence detection imaging in oncology: preliminary results and comparison with dedicated PET.

S. Vandenberghe, D. Huglo, Y. D'Asseler, 2002, Medical science monitor : international medical journal of experimental and clinical research.

Imaging of giant cell arteritis: evidence of splenic involvement using FDG positron emission tomography.

C. Van de Wiele, R. Dierckx, D. Vogelaers, 2000, Clinical nuclear medicine.

Tryptophane-based biphenylsulfonamide matrix metalloproteinase inhibitors as tumor imaging agents.

A. Noël, G. Slegers, C. Van de Wiele, 2005, Cancer biotherapy & radiopharmaceuticals.

Infarct size and recurrence of ventricular arrhythmias after defibrillator implantation

L. Jordaens, J. De Sutter, M. D. De Buyzere, 2000, European Journal of Nuclear Medicine.

Membrane type 1 matrix metalloproteinase detection in tumors, using the iodinated endogenous [123I]-tissue inhibitor 2 of metalloproteinases as imaging agent.

J. Foidart, L. Vervoort, C. Van de Wiele, 2010, Cancer biotherapy & radiopharmaceuticals.

The role of nuclear medicine imaging in routine assessment of infectious brain pathology.

K. Van Laere, I. Goethals, C. Van de Wiele, 2002, Nuclear medicine communications.

Combined effect of EPO and radiotherapy on the expression of endogenous molecular markers of tumor metabolism and metastasis.

P. Pauwels, C. Van de Wiele, R. Dierckx, 2009, Cancer biotherapy & radiopharmaceuticals.

Nuclear medicine in the prediction and detection of radiation associated normal tissue damage of kidney, brain, bone marrow and salivary glands.

W. De Neve, I. Goethals, C. Van de Wiele, 2003, Nuclear medicine communications.

Cobalt-57 and technetium-99m-HMPAO-labeled leukocytes for visualization of ischemic infarcts.

J. Korf, C. Van de Wiele, R. Dierckx, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radioimmunoimaging. Advances and prospects.

C. Van de Wiele, N. Mertens, H. Revets, 2004, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography.

G. Slegers, C. Van de Wiele, J. Vanderheyden, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

18-Fluorine Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Infection in the Postoperative Spine

C. Van de Wiele, R. Dierckx, D. Uyttendaele, 2003, Spine.

68Ga‐PSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli?

A. Maes, C. Van de Wiele, M. Sathekge, 2018, Clinical genitourinary cancer.

Assessment of Cancer-Associated Biomarkers by Positron Emission Tomography: Advances and Challenges

Roger Lecomte, Timothy J. McCarthy, Francesco Scopinaro, 2003, Disease markers.

Radiolabeled lipiodol therapy for hepatocellular carcinoma in patients awaiting liver transplantation: pathology of the explant livers and clinical outcome.

H. Van Vlierberghe, C. Van de Wiele, R. Troisi, 2005, Cancer biotherapy & radiopharmaceuticals.

Peptides as Quorum Sensing Molecules: Measurement Techniques and Obtained Levels In vitro and In vivo

Evelien Wynendaele, Frederick Verbeke, Christophe Van de Wiele, 2017, Front. Neurosci..

In Vitro Functional Quality Characterization of NOTA-Modified Somatropins.

A. Maes, C. Van de Wiele, S. de Saeger, 2017, Analytical chemistry.

Quality specifications for peptide drugs: a regulatory‐pharmaceutical approach

C. Van de Wiele, B. De Spiegeleer, C. Burvenich, 2009, Journal of peptide science : an official publication of the European Peptide Society.

Influence of farnesyl transferase inhibitor treatment on epidermal growth factor receptor status.

B. Cornelissen, G. Slegers, C. Van de Wiele, 2004, Nuclear medicine and biology.

Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma.

P. Pauwels, C. Van de Wiele, R. Dierckx, 2009, Histology and histopathology.

In Vivo Imaging of Apoptosis in Oncology: An Update

C. Reutelingsperger, C. Van de Wiele, M. Peeters, 2011, Molecular imaging.

CA 15.3 measurements for separating FDG PET/CT positive from negative findings in breast carcinoma recurrence

A. Maes, C. Van de Wiele, H. Pottel, 2014, Nuklearmedizin.

18-fluorodeoxyglucose positron emission tomography in nonendocrine neoplastic disorders of the gastrointestinal tract.

C. Van de Wiele, R. Dierckx, M. Peeters, 2003, Gastroenterology.

Expression of SGLT1, Bcl-2 and p53 in Primary Pancreatic Cancer Related to Survival

P. Pauwels, M. De Vos, C. Van de Wiele, 2008, Cancer investigation.

Radiolabeled annexin-V for monitoring treatment response in oncology.

C. Van de Wiele, R. Dierckx, A. Signore, 2004, Cancer biotherapy & radiopharmaceuticals.

68Ga-PSMA-HBED-CC PET/CT imaging in Black versus White South African patients with prostate carcinoma presenting with a low volume, androgen-dependent biochemical recurrence: a prospective study

A. Maes, C. Van de Wiele, M. Sathekge, 2017, Nuclear medicine communications.

68Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients

A. Maes, C. Van de Wiele, T. Lengana, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Adaptive response in patients treated with 131I.

H. Thierens, A. Vral, L. de Ridder, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Biodistribution and dosimetry of 99mTc-ciprofloxacin, a promising agent for the diagnosis of bacterial infection

H. Thierens, G. Slegers, C. Van de Wiele, 2001, European Journal of Nuclear Medicine.

Coincidence Camera FDG Imaging for the Diagnosis of Chronic Orthopedic Infections: A Feasibility Study

S. Vandenberghe, Y. D'Asseler, C. Van de Wiele, 2001, Journal of computer assisted tomography.

Molecular imaging of hypoxia with radiolabelled agents

Christophe Van de Wiele, C. Van de Wiele, R. Dierckx, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

Tumour angiogenesis pathways: related clinical issues and implications for nuclear medicine imaging

G. Slegers, C. Van de Wiele, R. Dierckx, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

The Quorum Sensing Peptides PhrG, CSP and EDF Promote Angiogenesis and Invasion of Breast Cancer Cells In Vitro

O. De Wever, K. Peremans, C. Van de Wiele, 2015, PloS one.

Scapular osteomyelitis as a rare complication of Staphylococcus aureus endocarditis: bone scintigraphy findings.

C. Van de Wiele, H. Ham, J. Mertens, 2010, Clinical nuclear medicine.

Quantitative pretreatment VOI analysis of liver metastases

A. Maes, Y. D'Asseler, C. Van de Wiele, 2013, Nuklearmedizin.

Biodistribution and dosimetry study of 123I‐rh‐annexin V in mice and humans

H. Thierens, G. Slegers, B. Van Den Bossche, 2003, Nuclear medicine communications.

Nuclear medicine imaging to predict response to radiotherapy: a review.

Ingeborg Goethals, Guido Slegers, Christophe Van de Wiele, 2003, International journal of radiation oncology, biology, physics.

99mTc-(CO)3 His-Annexin A5 Micro-SPECT Demonstrates Increased Cell Death by Irinotecan During the Vascular Normalization Window Caused by Bevacizumab

Steven Staelens, Marc Peeters, Patrick Pauwels, 2011, The Journal of Nuclear Medicine.

99mTc-HYNIC Annexin-V imaging of tumors and its relationship to response to radiotherapy and/or chemotherapy.

C. Van de Wiele, S. Rottey, L. Vakaet, 2007, The Quarterly Journal of Nuclear Medicine and Molecular Imaging.

Effect of AIDS on women who have sex-determined health issues.

A. Maes, C. Van de Wiele, E. Dadachova, 2014, Seminars in nuclear medicine.

Prognostic Value of Pre-treatment F-18 FDG PET Metabolic Metrics in Patients with Locally Advanced Carcinoma of the Anus with and without HIV Infection

A. Maes, C. Van de Wiele, M. Sathekge, 2018, Nuklearmedizin.

Biodistribution and dosimetry of (99m)Tc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies.

F Dumont, H Thierens, R A Dierckx, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

PSMA expression on neovasculature of solid tumors.

A. Maes, C. Van de Wiele, P. Debruyne, 2020, Histology and histopathology.

Characterization of FDG PET Images Using Texture Analysis in Tumors of the Gastro-Intestinal Tract: A Review

Anne-Leen Deleu, Machaba Junior Sathekge, Alex Maes, 2020, Biomedicines.

Bone scintigraphy of the hands in early stage lupus erythematosus and rheumatoid arthritis.

C. Van de Wiele, R. Dierckx, E. Veys, 1997, The Journal of rheumatology.

Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area.

A. Maes, C. Van de Wiele, H. Pottel, 2010, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases

C. Van de Wiele, R. Troisi, L. Libbrecht, 2012, British Journal of Cancer.

Radiolabeled estradiol derivatives to predict response to hormonal treatment in breast cancer: a review

G. Slegers, C. Van de Wiele, R. Dierckx, 2000, European Journal of Nuclear Medicine.

188Re-HDD/lipiodol for treatment of hepatocellular carcinoma: a feasibility study in patients with advanced cirrhosis.

H. Thierens, I. Colle, C. Van de Wiele, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The potential role of quorum-sensing peptides in oncology.

C. Van de Wiele, E. Wynendaele, B. De Spiegeleer, 2012, Medical hypotheses.

FDG PET for monitoring response to local and locoregional therapy in HCC and liver metastases.

A. Maes, C. Van de Wiele, R. Dierckx, 2009, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Gastrin-Releasing Peptide Receptor Imaging in Human Breast Carcinoma Versus Immunohistochemistry

Patrick Pauwels, Ingeborg Goethals, Christophe Van de Wiele, 2008, Journal of Nuclear Medicine.

Aseptic necrosis. A scintigraphic imitator of osseous involvement in Ga-67 avid lymphoma.

C. Van de Wiele, R. Dierckx, M. Simons, 1997, Clinical nuclear medicine.

Biological Characterisation of Somatropin-Derived Cryptic Peptides

A. Maes, C. Van de Wiele, F. Verbeke, 2018, International Journal of Peptide Research and Therapeutics.

Gallium-67 and technetium-99m-MDP scintigraphy for osseous involvement in lymphoma.

C. Van de Wiele, R. Dierckx, M. Simons, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Urinary excretion of tubular proteins and the technetium-99m dimercaptosuccinic acid (DMSA) absolute renal uptake in partial ureteral obstruction in rats: a functional evaluation of hydronephrotic kidneys

C. Van de Wiele, R. Dierckx, J. van de Voorde, 1999, Urological Research.

Blood-brain barrier transport kinetics of NOTA-modified proteins: the somatropin case.

A. Maes, C. Van de Wiele, Yorick Janssens, 2020, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

68Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans

A. Maes, C. Van de Wiele, I. Lawal, 2017, European Journal of Nuclear Medicine and Molecular Imaging.

Growth factor/peptide receptor imaging for the development of targeted therapy in oncology.

A. van Waarde, C. Van de Wiele, R. Dierckx, 2008, Current pharmaceutical design.

Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial.

T. Vercauteren, C. Van de Wiele, W. De Neve, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer.

Fréderic Duprez, Katrien Bonte, Christophe Van de Wiele, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Analytical characterization of NOTA-modified somatropins.

C. Van de Wiele, E. Wynendaele, B. De Spiegeleer, 2014, Journal of pharmaceutical and biomedical analysis.

The role of nuclear medicine in the prediction and detection of radiation-associated normal pulmonary and cardiac damage.

J. De Sutter, W. De Neve, I. Goethals, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The clinical value of nuclear medicine in the assessment of irradiation-induced and anthracycline-associated cardiac damage.

J. De Sutter, I. Goethals, C. Van de Wiele, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Leakage assessment in adjustable laparoscopic gastric banding: radiography versus 99mTc-pertechnetate scintigraphy

I. Goethals, B. Van Den Bossche, C. Van de Wiele, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals.

C. Van de Wiele, R. Dierckx, P. Elsinga, 2008, Current pharmaceutical design.

Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?

Debby Laukens, Christophe Van de Wiele, D. Laukens, 2013, Molecular imaging.

Probes for non-invasive matrix metalloproteinase-targeted imaging with PET and SPECT.

A. van Waarde, R. Bischoff, C. Van de Wiele, 2013, Current pharmaceutical design.

Cognitive neuroactivation using SPECT and the Stroop Colored Word Test in patients with diffuse brain injury.

Andreas Otte, Ingeborg Goethals, Christophe Van de Wiele, 2004, Journal of neurotrauma.

225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings

A. Maes, C. Van de Wiele, F. Bruchertseifer, 2023, European Journal of Nuclear Medicine and Molecular Imaging.

Carbonic anhydrase IX expression correlates with FDG uptake by primary non-small cell lung cancer.

J. V. van Meerbeeck, P. Pauwels, C. Van de Wiele, 2010, Cancer biotherapy & radiopharmaceuticals.

Visualization of the stomach on rhenium-186 HEDP imaging after therapy for metastasized prostate carcinoma.

C. Van de Wiele, R. Dierckx, B. Brans, 1999, Clinical nuclear medicine.

Radioiodinated recombinant human TSH: a novel radiopharmaceutical for thyroid cancer metastases detection.

B. Cornelissen, G. Slegers, C. Van de Wiele, 2004, Cancer biotherapy & radiopharmaceuticals.

Reproducibility of FDG PET based metabolic tumor volume measurements and of their FDG distribution within.

A. Maes, C. Van de Wiele, V. Cocquyt, 2015, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Lymphocyte labeling with technetium-99m-HMPAO: a radiotoxicity study using the micronucleus assay.

H. Thierens, A. Vral, L. de Ridder, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Relationship of decreased chemotaxis of technetium-99m-HMPAO-labeled lymphocytes to apoptosis.

H. Thierens, J. Philippé, C. Van de Wiele, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Yttrium-90 labelled resin microspheres for treatment of primary and secondary malignant liver tumors.

C. Van de Wiele, M. Peeters, L. Defreyne, 2009, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Estimation of risk based on biological dosimetry for patients treated with radioiodine.

H. Thierens, A. Vral, L. de Ridder, 1999, Nuclear medicine communications.

The Diagnostic Performance of 18F-PSMA-1007 PET/CT in Prostate Cancer Patients with Early Recurrence after Definitive Therapy with a PSA <10 ng/ml.

A. Maes, C. Van de Wiele, M. Sathekge, 2022, Nuklearmedizin. Nuclear medicine.

Biodistribution and displacement studies of the selective 5-HT2Areceptor antagonist 123I-5-I-R91150 in the normal dog

G. Slegers, K. Audenaert, K. Peremans, 2002, Nuclear medicine communications.

FDG uptake in lymph-nodes of HIV+ and tuberculosis patients: implications for cancer staging.

A. Maes, C. Van de Wiele, H. Pottel, 2010, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

False-Positive Axillary Lymph Nodes Due to Silicone Adenitis on (18)F-FDG PET/CT in an Oncological Setting.

A. Maes, C. Van de Wiele, O. Gheysens, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Tumor perfusion using first-pass F-18 FDG PET images.

I. Goethals, C. Van de Wiele, P. Smeets, 2012, Clinical nuclear medicine.

The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents

R. Dobson, C. Van de Wiele, A. Bronselaer, 2020, Journal of the American Medical Directors Association.

Age- and gender-specific differences in left ventricular cardiac function and volumes determined by gated SPET

J. De Sutter, G. De Backer, C. Van de Wiele, 2001, European Journal of Nuclear Medicine.

The Selvester 32-point QRS score for evaluation of myocardial infarct size after primary coronary angioplasty.

J. De Sutter, G. De Backer, M. D. De Buyzere, 1999, The American journal of cardiology.

Expression and prognostic value of glucose transporters and hexokinases in tonsil and mobile tongue squamous cell carcinoma.

P. Pauwels, C. Van de Wiele, H. Vermeersch, 2011, Histology and histopathology.

Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck

C. Van de Wiele, A. Signore, H. Vermeersch, 2008, Nuclear medicine communications.

New strategies in polypeptide and antibody synthesis: an overview.

Filip Devos, Dominique Vlieghe, Andrew Kelly, 2004, Cancer biotherapy & radiopharmaceuticals.

Statin Intake and All-Cause Mortality among Older Nursing Home Residents

C. Van de Wiele, N. Van Den Noortgate, A. Bronselaer, 2021, Gerontology.

Absence of increased Tc-99m polyclonal human immunoglobulin (HIG) joint uptake in a patient with systemic lupus erythematosus presenting with polyarticular joint complaints.

C. Van de Wiele, R. Dierckx, F. Jacobs, 2005, Clinical nuclear medicine.

False-Negative Tc-99m MIBI Scintigraphy in Histopathologically Proved Recurrent High-Grade Oligodendroglioma

I. Goethals, C. Van de Wiele, R. Dierckx, 2003, Clinical nuclear medicine.

Differences of cortical 5-HT2A receptor binding index with SPECT in subtypes of anorexia nervosa: relationship with personality traits?

G. Slegers, K. Audenaert, I. Goethals, 2007, Journal of psychiatric research.

Aseptic loosening of a knee prosthesis as imaged on FDG positron emission tomography.

C. Van de Wiele, R. Dierckx, P. de Bondt, 2000, Clinical nuclear medicine.

Quantitative Perfusion Scintigraphy or Anatomic Segment Method in lung cancer resection.

J. V. van Meerbeeck, T. Holvoet, C. Van de Wiele, 2011, Lung cancer.

Poststress left ventricular ejection fraction is an independent predictor of major cardiac events in patients with coronary artery disease and impaired left ventricular function.

J. De Sutter, G. De Backer, M. D. De Buyzere, 2008, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Biological Characterisation of Somatropin-Derived Cryptic Peptides

A. Maes, C. Van de Wiele, F. Verbeke, 2018, International Journal of Peptide Research and Therapeutics.

Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.

C. Van de Wiele, H. Vermeersch, K. Bonte, 2011, Cancer biotherapy & radiopharmaceuticals.

Comparison of cortical 5-HT2A receptor binding in bulimia nervosa patients and healthy volunteers.

Ingeborg Goethals, Guido Slegers, Christophe Van de Wiele, 2004, The American journal of psychiatry.

Is 99mTc human immunoglobulin G scintigraphy (HIG-scan) useful for the detection of spinal inflammation in ankylosing spondylitis?

C. Van de Wiele, R. Dierckx, E. Veys, 2000, Clinical and experimental rheumatology.

Laparoscopic adjustable silicone gastric banding leakage assessed by 99mTc-pertechnetate scintigraphy.

C. Van de Wiele, R. Dierckx, J. Versijpt, 1999, Journal of Nuclear Medicine.

Multimerization improves targeting of peptide radio-pharmaceuticals.

C. Van de Wiele, R. Dierckx, P. Elsinga, 2012, Current pharmaceutical design.

188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial.

H. Thierens, H. Van Vlierberghe, C. Van de Wiele, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Fasting blood glucose levels are related to exercise capacity in patients with coronary artery disease.

J. De Sutter, M. D. De Buyzere, C. Van de Wiele, 2006, American heart journal.

99mTc-Labeled Tricarbonyl His-CNA35 as an Imaging Agent for the Detection of Tumor Vasculature

Yves D'Asseler, Kathelijne Peremans, Christophe Van de Wiele, 2012, The Journal of Nuclear Medicine.

Radiolabeled immunotherapy in non-Hodgkin's lymphoma treatment: the next step

C. Van de Wiele, R. Dierckx, A. Otte, 2009, Nuclear medicine communications.

Patient-specific lean body mass can be estimated from limited-coverage computed tomography images

A. Maes, C. Van de Wiele, H. Pottel, 2018, Nuclear medicine communications.

Evaluation of CT-based SUV normalization

A. Maes, C. Van de Wiele, H. Pottel, 2016, Physics in medicine and biology.

Prognostic value of CD25 expression on lymphocytes and tumor cells in squamous-cell carcinoma of the head and neck.

C. Van de Wiele, R. Dierckx, A. Signore, 2008, Cancer biotherapy & radiopharmaceuticals.

Cobalt-57 as a SPET tracer in the visualization of ischaemic brain damage in patients with middle cerebral artery stroke.

J. Korf, C. Van de Wiele, R. Dierckx, 1998, Nuclear medicine communications.

Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial.

T. Vercauteren, W. De Gersem, C. Van de Wiele, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The immune system and cancer.

C. Van de Wiele, D. Loose, 2009, Cancer biotherapy & radiopharmaceuticals.

Variability study of a non-invasive approach to the absolute quantification of cerebral blood flow with 99Tcm-ECD using aortic activity as the arterial input estimate.

K. Van Laere, K. Audenaert, C. Van de Wiele, 1999, Nuclear medicine communications.

Use of 18F-FDG PET to Predict Response to First-Line Tuberculostatics in HIV-Associated Tuberculosis

A. Maes, C. Van de Wiele, M. Sathekge, 2011, The Journal of Nuclear Medicine.